Telemonitoring is fastest growing segment fueling the growth of Cardiovascular Monitoring And Diagnostic Devices market

 

The global Cardiovascular Monitoring And Diagnostic Devices Market is estimated to be valued at US$ 2,955.1 Mn or billions in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Cardiovascular monitoring and diagnostic devices are used to monitor and analyze the heart rate, blood pressure and other parameters. These devices aid in detection of cardiovascular diseases at an early stage and help physicians in effective treatment.

Market key trends:
Remote patient monitoring through telemonitoring devices is emerging as an important trend in the cardiovascular monitoring and diagnostic devices market. Telemonitoring devices allow continuous monitoring of patients at home and transfer of the records to healthcare professionals. They help in early detection of deteriorations or complications. The adoption of telemonitoring devices is expected to witness significant growth owing to increasing burden of cardiovascular diseases, rise in geriatric population and need for affordable long term care. Additionally, integration of IoT and AI in cardiovascular monitoring devices is enabling continuous analysis of vital parameters and predictive analysis to preempt cardiovascular events.
Segment Analysis
The global cardiovascular monitoring and diagnostic devices market is segmented on the basis of product type, end user and geography. By product type, the market is segmented into ECG systems, ECG management systems, holter monitors, event monitors, implantable loop recorders, cardiovascular diagnostic devices and others. Among these, the ECG systems hold a major share in the market owing to its wide range of applications in detecting cardiac anomalies. It is affordable, portable and provides accurate and real-time heart rate monitoring.

Key Takeaways
The global cardiovascular monitoring and diagnostic devices market is expected to witness high growth, exhibiting CAGR of 10.% over the forecast period, due to increasing prevalence of cardiovascular diseases.

The North American region dominates the global cardiovascular monitoring and diagnostic devices market owing to the rising geriatric population, increasing prevalence of cardiovascular diseases and developed healthcare infrastructure in the region.

Key players operating in the cardiovascular monitoring and diagnostic devices market are GE Healthcare, Philips Healthcare, Nihon Kohden, Schiller AG, Opto Circuits (India) Limited, Welch Allyn, Fukuda Denshi Co., Ltd, Lidco Group plc., Biotricity Inc., Bittium Corporation, VivaQuant. The global cardiovascular monitoring and diagnostic devices market size was valued at US$ 2,955.1 Mn in 2023 and expected to reach over US$ 7,000 Mn by 2030.

Comments

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure